CD1C and COVID-19: Whether or not patients with COVID-19 were previously hospitalized, the numbers of their CD1c+ myeloid DCs and pDCs were lower than those for healthy donors during the acute infection phase and even 7 months after the initial SARS-CoV-2 infection (Figure 3A) (Pérez-Gómez et al., 2021).